Mark A. Exley spends much of his time researching Immunology, CD1D, Natural killer T cell, T cell and Antigen. His research in Immunology intersects with topics in Animal model and Pharmacology. His CD1D research is under the purview of Immune system.
His Natural killer T cell study incorporates themes from Molecular biology, Adoptive cell transfer and Antigen-presenting cell. His T cell research is multidisciplinary, incorporating elements of Cytotoxic T cell and Cell biology. Mark A. Exley focuses mostly in the field of Antigen, narrowing it down to topics relating to Macrophage and, in certain cases, Interleukin 4, Granulocyte macrophage colony-stimulating factor and Bronchoalveolar lavage.
His main research concerns Immunology, Natural killer T cell, CD1D, Immune system and T cell. His is doing research in Cytokine, Immunotherapy, IL-2 receptor, Innate immune system and Antigen presentation, both of which are found in Immunology. Mark A. Exley has researched Natural killer T cell in several fields, including Adoptive cell transfer, Antigen-presenting cell and Cell biology.
His studies deal with areas such as Cell and MHC class I as well as Cell biology. His CD1D research includes elements of Inflammation and Cancer research. His study in Molecular biology extends to T cell with its themes.
Mark A. Exley mainly focuses on Immunology, Natural killer T cell, Immune system, CD1D and T-cell receptor. His research investigates the connection between Immunology and topics such as Peripheral blood mononuclear cell that intersect with problems in Asthma. His biological study spans a wide range of topics, including Cell, Nod and Interleukin 12, Interleukin 21, Lymphokine-activated killer cell.
Mark A. Exley interconnects CD1 and Cell biology in the investigation of issues within CD1D. His study looks at the relationship between T-cell receptor and fields such as Cancer research, as well as how they intersect with chemical problems. His biological study spans a wide range of topics, including Receptor and Primary sclerosing cholangitis.
The scientist’s investigation covers issues in Immunology, Immune system, Natural killer T cell, CD1D and Immunotherapy. His Immunology study integrates concerns from other disciplines, such as Receptor and Diet therapy. His research in Immune system intersects with topics in Endocrinology and Internal medicine.
His Internal medicine research incorporates themes from Leukocyte homeostasis and Cytotoxic T cell. Natural killer T cell is a subfield of Antigen that Mark A. Exley explores. His CD1D study incorporates themes from Cell growth, MHC class I, Cell biology, Double negative and Flow cytometry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
S. Brian Wilson;Sally C. Kent;Kurt T. Patton;Tihamer Orban.
Multiple immuno-regulatory defects in type-1 diabetes
Anjli Kukreja;Giulia Cost;John Marker;Chenhui Zhang.
Journal of Clinical Investigation (2002)
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis
Ivan J. Fuss;Frank Heller;Monica Boirivant;Francisco Leon.
Journal of Clinical Investigation (2004)
Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells
Mark Exley;Jorge A. Garcia;Steven P. Balk;Steven Porcelli.
Journal of Experimental Medicine (1997)
Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production
Lydia Lynch;Lydia Lynch;Michael Nowak;Bindu Varghese;Justice Clark.
Cd1-Reactive Natural Killer T Cells Are Required for Development of Systemic Tolerance through an Immune-Privileged Site
Koh Hei Sonoda;Mark Exley;Scott Snapper;Steven P. Balk.
Journal of Experimental Medicine (1999)
Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer
Syed Muhammad Ali Tahir;Olivia Cheng;Angela Shaulov;Yasuhiko Koezuka.
Journal of Immunology (2001)
Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets
Yuri N. Naumov;Keith S. Bahjat;Rudolph Gausling;Roshini Abraham.
Proceedings of the National Academy of Sciences of the United States of America (2001)
CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung
Edward E.S. Nieuwenhuis;Tetsuya Matsumoto;Mark Exley;Robbert A. Schleipman.
Nature Medicine (2002)
NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance
Koh-Hei Sonoda;Douglas E. Faunce;Masaru Taniguchi;Mark Exley.
Journal of Immunology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: